Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBT-248 in Healthy Adult Participants
NCT07905053Phase 1Recruiting
- Sponsor
- Cibus
- Start
- Oct 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of CBT-101 in chronic pancreatitis (CP) (4 cohorts), sponsored by Cibus. Primary endpoint: Adverse Events at Day 7. Started Oct 2026; status: recruiting.
02
Drugs
CBT-101
03
Conditions
chronic pancreatitis (CP)
Beyond the preview
Go deeper on NCT07905053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07905053.